1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Alpha-1 Antitrypsin (AAT) In-Cycle Grant Opportunities (Research Grant) is sponsored by Alpha-1 Foundation. This program funds meritorious research efforts designed to improve the health of individuals with Alpha-1 Antitrypsin Deficiency (AATD) with the ultimate goal of finding a cure.
The objective is to encourage the development of novel concepts to better understand the basic biology of alpha-1 antitrypsin expression and the pathogenesis/management of AAT Deficiency.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Investigators with novel concepts in Alpha-1 Antitrypsin Deficiency research. Nonprofits are eligible. Letter of Intent (LOI) submission is the first step. Confirm the full requirements in the official notice before applying.
The current listing shows up to $100,000 over a two-year period, or for 2 PI proposals, a maximum of $100,000 per year may be requested per institution. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Alpha-1 Antitrypsin (AAT) In-Cycle Grant Opportunities (Research Grant) is funded by Alpha-1 Foundation. Verify program details on the funder's official page before applying.
Yes — this listing is flagged as national in scope, so applicants across the U.S. may apply, subject to the sponsor's other eligibility criteria.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
Past winners and funding trends for this program